Trial intelligence / Profile preview

Avagard vs Purell on hand skin condition

NCT00731042Phase 4Completed

Sponsor
Solventum
Start
Mar 2008
Primary completion
Apr 2008
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of chlorhexidine + ethyl alcohol in Infection prevention (IPC), sponsored by Solventum. Primary endpoint: Visual Skin Score at 14 days. Started Mar 2008; status: completed.

02

Drugs

chlorhexidine + ethyl alcohol
03

Conditions

Infection prevention (IPC)

Beyond the preview

Go deeper on NCT00731042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00731042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call